BDBM72316 2-(5-isopropyl-6-methyl-benzofuran-3-yl)-N-(2-thenyl)acetamide::2-(6-methyl-5-propan-2-yl-1-benzofuran-3-yl)-N-(thiophen-2-ylmethyl)acetamide::2-(6-methyl-5-propan-2-yl-1-benzofuran-3-yl)-N-(thiophen-2-ylmethyl)ethanamide::2-(6-methyl-5-propan-2-yl-3-benzofuranyl)-N-(thiophen-2-ylmethyl)acetamide::MLS000336513::SMR000254067::cid_2469541

SMILES CC(C)c1cc2c(CC(=O)NCc3cccs3)coc2cc1C

InChI Key InChIKey=SFBPDXDLVQFAAQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72316   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72316BDBM72316(8,9-Difluoro-2-(trifluoromethyl)-10,11,12,13-tetra...)
Affinity DataIC50: 20nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent